Home
HSCS
HSCS News

Latest Heart Test Laboratories Inc. (HSCS) News on June 2, 2025

HeartSciences signs first MyoVista Insights platform customer

TipRanks

3 days ago

HeartSciences signs first MyoVista Insights platform customer

HeartSciences Signs First MyoVista Insights™ Platform Customer, Marking Major Commercial Milestone

GlobeNewswire

4 days ago

HeartSciences Signs First MyoVista Insights™ Platform Customer, Marking Major Commercial Milestone

HeartSciences’ CEO Andrew Simpson to Present at Emerging Growth Conference 82 on Wednesday, May 21, 2025

GlobeNewswire

13 days ago

HeartSciences’ CEO Andrew Simpson to Present at Emerging Growth Conference 82 on Wednesday, May 21, 2025

Presenting on Emerging Growth Conference 82 Day 1 on May 21; Register to live stream

GlobeNewswire

13 days ago

Presenting on Emerging Growth Conference 82 Day 1 on May 21; Register to live stream

HeartSciences to Host Investor Webinar and Q&A on Wednesday May 14, 2025 - Featuring CEO Andrew Simpson

GlobeNewswire

25 days ago

HeartSciences to Host Investor Webinar and Q&A on Wednesday May 14, 2025 - Featuring CEO Andrew Simpson

HeartSciences Adds Prominent Key Advisors to its Scientific Advisory Board

GlobeNewswire

a month ago

HeartSciences Adds Prominent Key Advisors to its Scientific Advisory Board

HeartSciences Announces Launch of MyoVista Insights™ Platform and Related Early Adopter Program

GlobeNewswire

a month ago

HeartSciences Announces Launch of MyoVista Insights™ Platform and Related Early Adopter Program

HeartSciences Provides Business Update and Reports Third Quarter Fiscal 2025 Financial Results

GlobeNewswire

3 months ago

HeartSciences Provides Business Update and Reports Third Quarter Fiscal 2025 Financial Results

HeartSciences Inc. Engages Integrous Communications to Enhance Investor Communications

GlobeNewswire

3 months ago

HeartSciences Inc. Engages Integrous Communications to Enhance Investor Communications

HeartSciences Provides Business Update and Reports Second Quarter Fiscal 2025 Financial Results

GlobeNewswire

6 months ago

HeartSciences Provides Business Update and Reports Second Quarter Fiscal 2025 Financial Results

HeartSciences’ AI-ECG Algorithms Assigned CMS Medicare and Medicaid Reimbursement

GlobeNewswire

7 months ago

HeartSciences’ AI-ECG Algorithms Assigned CMS Medicare and Medicaid Reimbursement

HeartSciences to Participate in the 2024 Maxim Healthcare Virtual Summit

GlobeNewswire

8 months ago

HeartSciences to Participate in the 2024 Maxim Healthcare Virtual Summit

HeartSciences Provides Business Update and Reports First Quarter Fiscal 2025 Financial Results

GlobeNewswire

9 months ago

HeartSciences Provides Business Update and Reports First Quarter Fiscal 2025 Financial Results

MT Newswires

9 months ago

Heart Test Laboratories Closes Non-Dilutive Financing; Shares Rise

HeartSciences Closes Non-Dilutive Financing to Increase its Cash Runaway Ahead of Upcoming FDA Submission

GlobeNewswire

9 months ago

HeartSciences Closes Non-Dilutive Financing to Increase its Cash Runaway Ahead of Upcoming FDA Submission

HeartSciences Provides Business Update and Reports Fiscal 2024 Financial Results

GlobeNewswire

10 months ago

HeartSciences Provides Business Update and Reports Fiscal 2024 Financial Results

Innovation Value Institute Analysis Demonstrates HeartSciences’ MyoVista® wavECG™ Potential to Improve Cardiovascular Pathway Efficiency

GlobeNewswire

10 months ago

Innovation Value Institute Analysis Demonstrates HeartSciences’ MyoVista® wavECG™ Potential to Improve Cardiovascular Pathway Efficiency

HeartSciences Selected to Demonstrate MyoVista® wavECG™ at the United Nations General Assembly Digital Health Symposium as a Technology to Radically Transform Healthcare

GlobeNewswire

10 months ago

HeartSciences Selected to Demonstrate MyoVista® wavECG™ at the United Nations General Assembly Digital Health Symposium as a Technology to Radically Transform Healthcare

HeartSciences Announces Allowance of U.S Patent for AI-ECG Assessment of Left Ventricular and Right Ventricular Heart Dysfunction

GlobeNewswire

a year ago

HeartSciences Announces Allowance of U.S Patent for AI-ECG Assessment of Left Ventricular and Right Ventricular Heart Dysfunction

HeartSciences Regains Compliance with Nasdaq Listing Requirements

GlobeNewswire

a year ago

HeartSciences Regains Compliance with Nasdaq Listing Requirements

HeartSciences Announces Further Internationalization of its AI-ECG Patent Portfolio

GlobeNewswire

a year ago

HeartSciences Announces Further Internationalization of its AI-ECG Patent Portfolio

HeartSciences Announces Grant of Fundamental Patent by the European Patent Office Covering Assessment of Diastolic Function of the Heart Using AI-ECG

GlobeNewswire

a year ago

HeartSciences Announces Grant of Fundamental Patent by the European Patent Office Covering Assessment of Diastolic Function of the Heart Using AI-ECG

HeartSciences to Present at the LD Micro Invitational XIV Conference

GlobeNewswire

a year ago

HeartSciences to Present at the LD Micro Invitational XIV Conference

HeartSciences Announces Podium Presentation at World Congress of Anesthesiologists on the Utility of MyoVista® Wavelet ECG For Detection of Left Ventricular Diastolic Dysfunction in Preoperative Patients

GlobeNewswire

a year ago

HeartSciences Announces Podium Presentation at World Congress of Anesthesiologists on the Utility of MyoVista® Wavelet ECG For Detection of Left Ventricular Diastolic Dysfunction in Preoperative Patients

Heart Test Laboratories Third Quarter 2024 Earnings: US$0.031 loss per share (vs US$0.16 loss in 3Q 2023)

Simply Wall St.

a year ago

Heart Test Laboratories Third Quarter 2024 Earnings: US$0.031 loss per share (vs US$0.16 loss in 3Q 2023)

HeartSciences Reports Third Quarter Fiscal 2024 Financial Results

GlobeNewswire

a year ago

HeartSciences Reports Third Quarter Fiscal 2024 Financial Results

HeartSciences’ Announces Peer-Reviewed Publication Evaluating Use of MyoVista® Technology to Detect Asymptomatic Left Ventricular Dysfunction in Patients with Type 2 Diabetes

GlobeNewswire

a year ago

HeartSciences’ Announces Peer-Reviewed Publication Evaluating Use of MyoVista® Technology to Detect Asymptomatic Left Ventricular Dysfunction in Patients with Type 2 Diabetes

HeartSciences Announces Canada Patent Grant Covering MyoVista® Wavelet Technology

GlobeNewswire

a year ago

HeartSciences Announces Canada Patent Grant Covering MyoVista® Wavelet Technology

HeartSciences Adds Key Advisor to its Scientific Advisory Board

GlobeNewswire

a year ago

HeartSciences Adds Key Advisor to its Scientific Advisory Board

HeartSciences Expands its Scientific Advisory Board

GlobeNewswire

a year ago

HeartSciences Expands its Scientific Advisory Board

Business Wire

a year ago

MFS Announces Closed-End Fund Distributions

HeartSciences Appoints New Scientific Advisory Board Member

GlobeNewswire

a year ago

HeartSciences Appoints New Scientific Advisory Board Member

NeurAxis Appoints Timothy Henrichs as Chief Financial Officer

GlobeNewswire

a year ago

NeurAxis Appoints Timothy Henrichs as Chief Financial Officer

LiveOne’s (Nasdaq: LVO) Slacker Radio Partners With Legible Inc. Giving Access to Millions of Audiobooks and Ebooks for Its Members, Including Audiobook Previews for 1.5M+ Tesla Drivers

GlobeNewswire

a year ago

LiveOne’s (Nasdaq: LVO) Slacker Radio Partners With Legible Inc. Giving Access to Millions of Audiobooks and Ebooks for Its Members, Including Audiobook Previews for 1.5M+ Tesla Drivers

Summit State Bank Reports Net Income of $10.8 Million for the Year 2023; Declares Quarterly Cash Dividend of $0.12 Per Common Share

GlobeNewswire

a year ago

Summit State Bank Reports Net Income of $10.8 Million for the Year 2023; Declares Quarterly Cash Dividend of $0.12 Per Common Share

Investors in LightPath Technologies (NASDAQ:LPTH) have unfortunately lost 66% over the last three years

Simply Wall St.

a year ago

Investors in LightPath Technologies (NASDAQ:LPTH) have unfortunately lost 66% over the last three years

True Velocity, FN America Approaching Launch of Conversion Kits for M240

GlobeNewswire

a year ago

True Velocity, FN America Approaching Launch of Conversion Kits for M240

Bank of the James Financial Group, Inc. Announces Quarterly Dividend; Increases Quarterly Dividend by 25%

GlobeNewswire

a year ago

Bank of the James Financial Group, Inc. Announces Quarterly Dividend; Increases Quarterly Dividend by 25%

SEALSQ Unveils AIoT Strategy with WISeAI.IO at Davos AI Roundtable

GlobeNewswire

a year ago

SEALSQ Unveils AIoT Strategy with WISeAI.IO at Davos AI Roundtable

HeartSciences Announces Results and Adjournment of Annual Shareholder Meeting

GlobeNewswire

a year ago

HeartSciences Announces Results and Adjournment of Annual Shareholder Meeting

SEALSQ Launches SEALCOIN at Davos Event

GlobeNewswire

a year ago

SEALSQ Launches SEALCOIN at Davos Event

SeaStar Medical Appoints David A. Green as Chief Financial Officer

GlobeNewswire

a year ago

SeaStar Medical Appoints David A. Green as Chief Financial Officer

AmpliTech Group Unveils AGTGSS Flagship Product, A Massive MIMO, 64T64R ORAN, CAT B Radio And Launches New AGTGSS Division Website

GlobeNewswire

a year ago

AmpliTech Group Unveils AGTGSS Flagship Product, A Massive MIMO, 64T64R ORAN, CAT B Radio And Launches New AGTGSS Division Website

Akoustis Receives Wi-Fi 7 Design Win from Tier-1 Enterprise Wi-Fi AP Provider

GlobeNewswire

a year ago

Akoustis Receives Wi-Fi 7 Design Win from Tier-1 Enterprise Wi-Fi AP Provider

Business Wire

a year ago

Boxlight Corporation Board of Directors Announces Leadership Changes

Business Wire

a year ago

Boxlight Announces Licensed EDLA MimioPro G Interactive Flat Panel with Google Certified Professional Development for Educators

SELLAS Life Sciences Announces Proposed Public Offering

GlobeNewswire

a year ago

SELLAS Life Sciences Announces Proposed Public Offering

HeartSciences Reminds Stockholders to Vote at the Upcoming Annual Shareholder Meeting

GlobeNewswire

a year ago

HeartSciences Reminds Stockholders to Vote at the Upcoming Annual Shareholder Meeting

GlobeNewswire

a year ago

XBP Europe to Ring Nasdaq Opening Bell on January 5, 2024

Arbe to Participate at 26th Annual Needham Growth Conference

GlobeNewswire

a year ago

Arbe to Participate at 26th Annual Needham Growth Conference

RADCOM to Present at the 26th Annual Needham Growth Conference on Thursday, January 18

PR Newswire

a year ago

RADCOM to Present at the 26th Annual Needham Growth Conference on Thursday, January 18

Regis Announces Listing Transfer to The Nasdaq Stock Market LLC

Business Wire

a year ago

Regis Announces Listing Transfer to The Nasdaq Stock Market LLC

Clough Global Opportunities Fund Section 19(a) Notice

ACCESSWIRE

a year ago

Clough Global Opportunities Fund Section 19(a) Notice

BARK Announces Departure of Chief Technology Officer

Business Wire

a year ago

BARK Announces Departure of Chief Technology Officer

Business Wire

a year ago

Aptorum Group Limited Reports Financial Results and Business Update for the Six Months Ended June 30, 2023

Business Wire

a year ago

Aptorum Group Limited Announces Results of 2023 Annual General Meeting of Shareholders

Shapeways Holdings, Inc. Announces Reductions in Force and Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

a year ago

Shapeways Holdings, Inc. Announces Reductions in Force and Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire

a year ago

MFS Releases Closed-End Fund Income Distribution Sources for Certain Funds

NeurAxis, Inc. Issues Letter to Shareholders from Brian Carrico, President and Chief Executive Officer

GlobeNewswire

a year ago

NeurAxis, Inc. Issues Letter to Shareholders from Brian Carrico, President and Chief Executive Officer

Newswire Named Leader in Press Release Distribution in G2's Winter 2024 Report

ACCESSWIRE

a year ago

Newswire Named Leader in Press Release Distribution in G2's Winter 2024 Report

We Think Research Frontiers (NASDAQ:REFR) Needs To Drive Business Growth Carefully

Simply Wall St.

a year ago

We Think Research Frontiers (NASDAQ:REFR) Needs To Drive Business Growth Carefully

HeartSciences Reports Second Quarter Fiscal 2024 Financial Results

GlobeNewswire

a year ago

HeartSciences Reports Second Quarter Fiscal 2024 Financial Results

Airspeeder, Veritone and base Revolutionise eVTOL Racing Series With Digital Media Hub Partnership

Business Wire

a year ago

Airspeeder, Veritone and base Revolutionise eVTOL Racing Series With Digital Media Hub Partnership

Johnson Outdoors' (JOUT) Q4 Earnings and Sales Miss Estimates

Zacks

a year ago

Johnson Outdoors' (JOUT) Q4 Earnings and Sales Miss Estimates

Meta Materials Releases Board Letter to Shareholders

ACCESSWIRE

a year ago

Meta Materials Releases Board Letter to Shareholders

Business Wire

a year ago

Boxlight Celebrates Denver Public Schools' Success with MimioSTEM Solutions

7 Heavily De-Risked Tech Stocks Worth Another Look

InvestorPlace

a year ago

7 Heavily De-Risked Tech Stocks Worth Another Look

HeartSciences Receives FDA Confirmation for 510(k) Clearance Pathway

GlobeNewswire

a year ago

HeartSciences Receives FDA Confirmation for 510(k) Clearance Pathway

Down -38.07% in 4 Weeks, Here's Why You Should You Buy the Dip in Trevi Therapeutics, Inc. (TRVI)

Zacks

2 years ago

Down -38.07% in 4 Weeks, Here's Why You Should You Buy the Dip in Trevi Therapeutics, Inc. (TRVI)

Deswell Industries (NASDAQ:DSWL) Has Affirmed Its Dividend Of $0.10

Simply Wall St.

2 years ago

Deswell Industries (NASDAQ:DSWL) Has Affirmed Its Dividend Of $0.10

Upexi Revenue Increases 144% Year-Over-Year and 53.5% Sequentially to $27.3 Million for Fiscal First Quarter 2024

ACCESSWIRE

2 years ago

Upexi Revenue Increases 144% Year-Over-Year and 53.5% Sequentially to $27.3 Million for Fiscal First Quarter 2024

HeartSciences Announces Closing of License Agreements with the Icahn School of Medicine at Mount Sinai to Develop and Commercialize AI Cardiovascular Algorithms

GlobeNewswire

2 years ago

HeartSciences Announces Closing of License Agreements with the Icahn School of Medicine at Mount Sinai to Develop and Commercialize AI Cardiovascular Algorithms

Aptorum Group Limited to Hold Annual General Meeting of Shareholders on December 20, 2023

Business Wire

2 years ago

Aptorum Group Limited to Hold Annual General Meeting of Shareholders on December 20, 2023

Thomson Reuters StreetEvents

2 years ago

Q3 2023 BioXcel Therapeutics Inc Earnings Call

Lilium Partners With Industrial Leader DENSO to Prepare Production Ramp-Up of the Lilium Jet’s Innovative Electric Engine

GlobeNewswire

2 years ago

Lilium Partners With Industrial Leader DENSO to Prepare Production Ramp-Up of the Lilium Jet’s Innovative Electric Engine

HeartSciences’ MyoVista® wavECGTM Selected for Heart Screening of Irish Garda National Police Officers

GlobeNewswire

2 years ago

HeartSciences’ MyoVista® wavECGTM Selected for Heart Screening of Irish Garda National Police Officers

Optex Systems Announces $1.3 Million Order for Laser Filter Units

ACCESSWIRE

2 years ago

Optex Systems Announces $1.3 Million Order for Laser Filter Units

CPI Card Group Inc. (NASDAQ:PMTS) Analysts Are More Bearish Than They Used To Be

Simply Wall St.

2 years ago

CPI Card Group Inc. (NASDAQ:PMTS) Analysts Are More Bearish Than They Used To Be

ProPhase Labs Inc (PRPH) Reports Mixed Q3 Results Amid Strategic Transformations

GuruFocus.com

2 years ago

ProPhase Labs Inc (PRPH) Reports Mixed Q3 Results Amid Strategic Transformations

Assembly Biosciences Names Anuj Gaggar, MD, PhD, as Chief Medical Officer

GlobeNewswire

2 years ago

Assembly Biosciences Names Anuj Gaggar, MD, PhD, as Chief Medical Officer

Xunlei Limited Schedules 2023 Unaudited Third Quarter Earnings Release on November 14, 2023

GlobeNewswire

2 years ago

Xunlei Limited Schedules 2023 Unaudited Third Quarter Earnings Release on November 14, 2023

eFFECTOR Therapeutics to Participate in Fireside Chat at 2023 Stifel Healthcare Conference

GlobeNewswire

2 years ago

eFFECTOR Therapeutics to Participate in Fireside Chat at 2023 Stifel Healthcare Conference

Eledon Reports Updated Data from Ongoing Phase 1b Trial Evaluating Tegoprubart for Prevention of Rejection in Kidney Transplantation

GlobeNewswire

2 years ago

Eledon Reports Updated Data from Ongoing Phase 1b Trial Evaluating Tegoprubart for Prevention of Rejection in Kidney Transplantation

Associated Press Finance

2 years ago

Beasley: Q3 Earnings Snapshot

Share on Social Networks: